Radiobiology

Loyola Medicine/Palos Health Installs ViewRay's MRIdian Linac System for MR Image-Guided Radiation Therapy

Retrieved on: 
Monday, July 9, 2018

CLEVELAND, July 9, 2018 /PRNewswire/ --ViewRay, Inc. (Nasdaq: VRAY)announced today that Palos Health, in partnership with Loyola Medicine, has installed ViewRay's MRIdian Linac System for MR image-guided radiation therapy at its Palos Health South Campus in Orland Park, Illinois.

Key Points: 
  • CLEVELAND, July 9, 2018 /PRNewswire/ --ViewRay, Inc. (Nasdaq: VRAY)announced today that Palos Health, in partnership with Loyola Medicine, has installed ViewRay's MRIdian Linac System for MR image-guided radiation therapy at its Palos Health South Campus in Orland Park, Illinois.
  • "It's exciting to be the first community hospital to incorporate the MRIdian Linac system, as we believe MR image-guided radiation therapy will become a standard of care for all radiation oncology departments in the future."
  • ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian radiation therapy system.
  • MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology.

Global Radiation Detection, Monitoring and Safety Industry

Retrieved on: 
Wednesday, July 4, 2018

Table 77: Asia-Pacific Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Key Points: 
  • Table 77: Asia-Pacific Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 78: Asia-Pacific Historic Review for Radiation Detection, Monitoring & Safety Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 79: Asia-Pacific 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 80: Asia-Pacific Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 81: Asia-Pacific Historic Review for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 82: Asia-Pacific 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Percentage Breakdown of Dollar Sales for Healthcare, Manufacturing, Nuclear Power, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 83: New Cancer Cases in China by Gender and Affected Site: 2015 (In Thousands) (includes corresponding Graph/Chart)
    Table 84: Cancer Related Mortality in China by Gender and Affected Site: 2015 (In Thousands) (includes corresponding Graph/Chart)
    Table 85: Chinese Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 86: Chinese Historic Review for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 87: Chinese 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Percentage Breakdown of Dollar Sales for Healthcare, Manufacturing, Nuclear Power, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 88: Indian Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 89: Indian Historic Review for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 90: Indian 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Percentage Breakdown of Dollar Sales for Healthcare, Manufacturing, Nuclear Power, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 91: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 92: Rest of Asia-Pacific Historic Review for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 93: Rest of Asia-Pacific 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Percentage Breakdown of Dollar Sales for Healthcare, Manufacturing, Nuclear Power, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 94: Middle East & Africa Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 95: Middle East & Africa Historic Review for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 96: Middle East & Africa 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Percentage Breakdown of Dollar Sales for Healthcare, Manufacturing, Nuclear Power, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 97: Latin American Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 98: Latin American Historic Review for Radiation Detection, Monitoring & Safety Devices by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 99: Latin American 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 100: Latin American Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 101: Latin American Historic Review for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 102: Latin American 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Percentage Breakdown of Dollar Sales for Healthcare, Manufacturing, Nuclear Power, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 103: Brazilian Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 104: Brazilian Historic Review for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 105: Brazilian 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Percentage Breakdown of Dollar Sales for Healthcare, Manufacturing, Nuclear Power, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)
    Table 106: Rest of Latin American Recent Past, Current and Future Analysis for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
    Table 107: Rest of Latin American Historic Review for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Healthcare, Manufacturing, Nuclear Power, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
    Table 108: Rest of Latin American 14-Year Perspective for Radiation Detection, Monitoring & Safety Devices by End-Use Sector - Percentage Breakdown of Dollar Sales for Healthcare, Manufacturing, Nuclear Power, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

RaySearch Laboratories: Provision CARES Proton Therapy Center in Knoxville, Tennessee, US, Treats First Patients Using RayStation and the New ProNova SC360 Proton System

Retrieved on: 
Tuesday, July 3, 2018

In 2014, Provision became the first center in the world to use RayStation for clinical proton treatments.

Key Points: 
  • In 2014, Provision became the first center in the world to use RayStation for clinical proton treatments.
  • The Provision network has continued to push the boundaries of radiation therapy, when adding the ProNova SC360 proton system, and treating the first patient in February 2018.
  • Johan Lf, CEO of RaySearch, says: "We are very pleased to support the Provision CARES Proton Therapy Network in achieving this treatment milestone with a state-of-the-art proton therapy solution.
  • Provision CARES Proton Therapy Center in Knoxville is the first cancer treatment center of its kind in Tennessee.

The Ottawa Hospital Becomes the 500th Customer for RayStation Treatment Planning System

Retrieved on: 
Monday, July 2, 2018

STOCKHOLM, July 2, 2018 /PRNewswire/ -- The Ottawa Hospital has placed an order for RayStation, RaySearch's innovative radiation therapy treatment planning system, becoming the 500th customer.

Key Points: 
  • STOCKHOLM, July 2, 2018 /PRNewswire/ -- The Ottawa Hospital has placed an order for RayStation, RaySearch's innovative radiation therapy treatment planning system, becoming the 500th customer.
  • Since the first sale in 2009, RaySearch has worked hard to ensure that RayStation remains the premier treatment planning system, covering the broadest range of treatment delivery machines and providing the most comprehensive functionality.
  • Dr. Jason Pantarotto, head of the Radiation Medicine Program at The Ottawa Hospital, says: "RayStation will complement our existing technology quite nicely, leading to efficiencies in treatment planning across multiple platforms.
  • RayStation integrates all RaySearch's advanced treatment planning solutions into a flexible treatment planning system.

RaySearch Laboratories: MedStar Georgetown University Hospital now Clinical With RayStation and Hyperscan

Retrieved on: 
Tuesday, June 26, 2018

STOCKHOLM, June 26, 2018 /PRNewswire/ --MedStar Georgetown University Hospital in Washington, D.C., has begun patient treatments using the RayStation treatment planning system in combination with Mevion's Hyperscan pencil beam scanning system.

Key Points: 
  • STOCKHOLM, June 26, 2018 /PRNewswire/ --MedStar Georgetown University Hospital in Washington, D.C., has begun patient treatments using the RayStation treatment planning system in combination with Mevion's Hyperscan pencil beam scanning system.
  • The combination of RayStation and Mevion's Hyperscan technology enables clinicians at MedStar Georgetown to plan and treat patients with the advantage of very sharp field edges and minimized radiation to critical structures.
  • Johan Lf, CEO of RaySearch, says: "We are very pleased to see this groundbreaking patient treatment at MedStar Georgetown, using RayStation in combination with Mevion's Hyperscan technology.
  • Proton therapy is an important focus area and RaySearch is committed to supporting all the latest techniques and systems.

University of Wisconsin Begins Patient Treatments with ViewRay's MRIdian Linac

Retrieved on: 
Thursday, June 21, 2018

CLEVELAND, June 21, 2018 /PRNewswire/-- ViewRay, Inc. (Nasdaq: VRAY)announced today that University of Wisconsin Carbone Cancer Center in Madison, Wisconsin, has begun patient treatments with the company's MRIdian Linac, following an upgrade of the hospital's original MRIdian System.

Key Points: 
  • CLEVELAND, June 21, 2018 /PRNewswire/-- ViewRay, Inc. (Nasdaq: VRAY)announced today that University of Wisconsin Carbone Cancer Center in Madison, Wisconsin, has begun patient treatments with the company's MRIdian Linac, following an upgrade of the hospital's original MRIdian System.
  • The next-generation MRIdian Linac combines the benefits of MR-image guidance with linear accelerator radiation delivery for the precision treatment of cancer.
  • With its new MRIdian Linac, the hospital gains significant improvements such as greater treatment efficiency and sharper beams, with all the clinical benefits of real-time MRI-targeting, tracking and adaptive therapy.
  • In addition to greater targeting precision, MRIdian Linac delivers radiation dose up to three times faster than the previous generation MRIdian system.

The nuclear medicine market is projected to grow at a CAGR of 5.9%

Retrieved on: 
Wednesday, June 20, 2018

The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018.

Key Points: 
  • The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018.
  • However, the short half-life of radiopharmaceuticals, hospital budget cuts, and high equipment prices are likely to restrain market growth.
  • Based on type, the nuclear medicine market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals.The diagnostic radiopharmaceuticals have been segmented into SPECT and PET radiopharmaceuticals.
  • The nuclear medicine market is divided into four major regions North America, Europe, Asia Pacific, and the Rest of the World.North America accounted for the largest share of the nuclear medicine market.

Global Nuclear Medicine/Radiopharmaceuticals Market 2018-2023: Major Players are Cardinal Health, GE Healthcare, and Curium

Retrieved on: 
Tuesday, June 19, 2018

By type, the global nuclear medicine market is segmented diagnostic and therapeutic nuclear medicine.

Key Points: 
  • By type, the global nuclear medicine market is segmented diagnostic and therapeutic nuclear medicine.
  • Based on applications, the nuclear medicine market is segmented into diagnostic and therapeutic applications.
  • The SPECT application segment accounted for the largest share of the diagnostic nuclear medicine market by applications owing to the rising demand for cardiac imaging.
  • Based on procedural volume, the nuclear medicine market is segmented into volumes for diagnostic and therapeutic procedures.

Nuclear Medicine/Radiopharmaceuticals Market Worth 5.26 Billion USD by 2023

Retrieved on: 
Thursday, June 14, 2018

According to a new market research report "Nuclear Medicine/Radiopharmaceuticals Marketby Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023", published by MarketsandMarkets, the global market is expected to grow at a CAGR of 5.9% during the forecast period, to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018.

Key Points: 
  • According to a new market research report "Nuclear Medicine/Radiopharmaceuticals Marketby Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023", published by MarketsandMarkets, the global market is expected to grow at a CAGR of 5.9% during the forecast period, to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018.
  • Based on type, the Nuclear Medicine Market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals.
  • In 2017, the Tc-99m segment accounted for the largest share of the nuclear medicine SPECT Radiopharmaceuticals Market.
  • The oncology segment is projected to account for the largest share of the PET Nuclear Medicine Market during the forecast period.

Pioneer of MR Image-Guided Radiotherapy, Washington University, Begins First Clinical Treatments with its Second ViewRay MRIdian System

Retrieved on: 
Wednesday, June 13, 2018

Siteman is the first U.S. cancer center to offer cancer therapy with both MRIdian and MRIdian Linac, furthering its leadership role in MR image-guided radiation therapy.

Key Points: 
  • Siteman is the first U.S. cancer center to offer cancer therapy with both MRIdian and MRIdian Linac, furthering its leadership role in MR image-guided radiation therapy.
  • Washington University physicians and researchers at Siteman played an integral role in the development, testing and clinical introduction of MRIdian in 2012.
  • Unlike conventional radiotherapy, MRIdian Linac technology uses high-definition MR soft-tissue imaging to visualize and track the detailed contours of the tumor and adjacent healthy tissues.
  • MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology.